Tri-Source Pharma Revenue and Competitors
Estimated Revenue & Valuation
- Tri-Source Pharma's estimated annual revenue is currently $4M per year.
- Tri-Source Pharma's estimated revenue per employee is $155,000
Employee Data
- Tri-Source Pharma has 26 Employees.
- Tri-Source Pharma grew their employee count by 53% last year.
Tri-Source Pharma's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder, Chairman, CEO | Reveal Email/Phone |
2 | Chief Commercial Officer, EVP at Tri-Source Pharma | Reveal Email/Phone |
3 | Director IT and Software Development | Reveal Email/Phone |
4 | Director Finance | Reveal Email/Phone |
5 | President, COO | Reveal Email/Phone |
6 | Staff Accountant | Reveal Email/Phone |
7 | Digital Marketing Executive | Reveal Email/Phone |
Tri-Source Pharma Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $17.5M | 113 | 14% | N/A | N/A |
#2 | $1.9M | 12 | 0% | N/A | N/A |
#3 | $1.1M | 7 | 0% | N/A | N/A |
#4 | $4.5M | 29 | 21% | N/A | N/A |
#5 | $4.8M | 31 | 11% | N/A | N/A |
#6 | $3.1M | 20 | N/A | N/A | N/A |
#7 | $0.8M | 5 | 0% | N/A | N/A |
#8 | $1.1M | 7 | 0% | N/A | N/A |
#9 | $2.6M | 17 | 6% | N/A | N/A |
#10 | $0.6M | 4 | -56% | N/A | N/A |
What Is Tri-Source Pharma?
Established in 2016, Tri-Source Pharma was formed for capital investment and management oversight of its subsidiary companies. Its goal is to grow and synergize each of its companies’ ability to expand. Tri-Source has a network of over 60,000 veterinary hospitals and over 150,000 human healthcare providers nationwide, which substantiates its positioning for solid, domestic and global expansion into the Americas and European markets.
keywords:N/AN/A
Total Funding
26
Number of Employees
$4M
Revenue (est)
53%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.7M | 26 | -28% | N/A |
#2 | $3.7M | 26 | -7% | N/A |
#3 | $4M | 26 | -59% | N/A |
#4 | $2.6M | 26 | 0% | N/A |
#5 | $5.9M | 26 | 30% | N/A |